Suppr超能文献

在信使核糖核酸转录过程中,离液剂对双链核糖核酸的还原作用。

Double-stranded RNA reduction by chaotropic agents during transcription of messenger RNA.

作者信息

Piao Xijun, Yadav Vibha, Wang Eddie, Chang Wayne, Tau Lanna, Lindenmuth Benjamin E, Wang Sharon X

机构信息

Technical Development, Ultragenyx Pharmaceutical Inc., 5000 Marina Blvd., Brisbane, CA 94005, USA.

出版信息

Mol Ther Nucleic Acids. 2022 Aug 4;29:618-624. doi: 10.1016/j.omtn.2022.08.001. eCollection 2022 Sep 13.

Abstract

-transcribed messenger RNA (mRNA) has recently shown increasing significance in the development of vaccines and therapeutics. Immunogenic double-stranded RNA (dsRNA) is an undesired byproduct formed during transcription (IVT), and it is challenging to reduce dsRNA byproduct from mRNA due to their similar sizes and intrinsic characteristics. Removal of dsRNA relies heavily on post-IVT chromatography purifications, such as reverse-phase high-pressure liquid chromatography, which increase manufacturing costs, reduce yield, and often decrease integrity, especially for long mRNA. Thus, it would be ideal to reduce and control the level of dsRNA during IVT. We herein present a simple, scalable, and controllable method to reduce the formation of dsRNA byproducts during IVT. Selected chaotropic agents at optimized concentrations are included during IVT to create a mild denaturing environment to prevent the undesired intermolecular or intramolecular base-pairing that is thought to promote RNA-templated dsRNA formation by RNA polymerase. Compared with regular IVT, our improved method produces mRNA with significantly less dsRNA, much lower immuno-stimulation, and more efficient protein expression. Therefore, this method potentially eliminates dsRNA removal purification steps and does not require reduced magnesium concentration, elevated temperature, or custom reagents, enabling a straightforward, high-yield, and cost-effective scale-up approach for mRNA manufacturing.

摘要

转录信使核糖核酸(mRNA)最近在疫苗和治疗药物的研发中显示出越来越重要的意义。免疫原性双链核糖核酸(dsRNA)是转录过程(体外转录,IVT)中形成的不良副产物,由于其大小和固有特性相似,从mRNA中减少dsRNA副产物具有挑战性。dsRNA的去除严重依赖于IVT后的色谱纯化,如反相高压液相色谱,这会增加制造成本、降低产量,并且常常降低完整性,尤其是对于长mRNA而言。因此,在IVT过程中减少并控制dsRNA的水平将是理想的。我们在此提出一种简单、可扩展且可控的方法,以减少IVT过程中dsRNA副产物的形成。在IVT过程中加入优化浓度的特定离液剂,以营造温和的变性环境,防止不期望的分子间或分子内碱基配对,这种碱基配对被认为会促进RNA聚合酶以RNA为模板形成dsRNA。与常规IVT相比,我们改进的方法产生的mRNA中dsRNA显著减少,免疫刺激更低,蛋白质表达更高效。因此,该方法有可能省去dsRNA去除纯化步骤,并且不需要降低镁浓度、升高温度或使用定制试剂,从而实现一种直接、高产且经济高效的mRNA规模化制备方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f968/9421179/f6c3fec87627/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验